VORICONAZOLE ACTAVIS voriconazole 50mg tablet blister pack

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

voriconazole, Quantity: 50 mg

Disponibil de la:

Medis Pharma Pty Ltd

INN (nume internaţional):

Voriconazole

Forma farmaceutică:

Tablet, film coated

Compoziție:

Excipient Ingredients: lactose monohydrate; magnesium stearate; povidone; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; macrogol 3350

Calea de administrare:

Oral

Unități în pachet:

50, 56, 100, 28, 20, 2, 14, 10, 30

Tip de prescriptie medicala:

(S4) Prescription Only Medicine

Indicații terapeutice:

VORICONAZOLE ACTAVIS is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Rezumat produs:

Visual Identification: white, round biconvex tablets, debossed 'VC50' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Statutul autorizaţiei:

Licence status A

Data de autorizare:

2015-02-02